Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 42, Issue 10 (Oct 2004)

Issues

Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency

Wolfgang Herrmann
  • Department of Clinical Chemistry/Central Laboratory, University Hospital of the Saarland, Homburg, Germany
/ Ulrich Hübner
  • Department of Clinical Chemistry/Central Laboratory, University Hospital of the Saarland, Homburg, Germany
/ Ines Koch
  • Department of Gynecology and Obstetrics, Central Hospital, Suhl, Germany
/ Rima Obeid
  • Department of Clinical Chemistry/Central Laboratory, University Hospital of the Saarland, Homburg, Germany
/ Ulrich Retzke
  • Department of Gynecology and Obstetrics, Central Hospital, Suhl, Germany
/ Jürgen Geisel
  • Department of Clinical Chemistry/Central Laboratory, University Hospital of the Saarland, Homburg, Germany
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2004.228

Abstract

Hyperhomocysteinemia is a risk factor in obstetrical complications such as pre-eclampsia, ‘hemolysis, elevated liver enzymes, low platelet’ (HELLP)-syndrome and placental insufficiency. The aim of our study was to investigate the alterations of homocysteine catabolism in these patients in relation to serum B-vitamins and renal function. Maternal fasting serum from preeclampsia (n = 24), HELLP (n = 20) and placental insufficiency (n = 25) patients at the time of diagnosis and pregnant controls (n = 34) was analyzed for homocysteine and its metabolites cystathionine and methylmalonic acid, the vitamins B6, B12 and folate, renal and additional parameters. Cystathionine, a parameter of homocysteine catabolism, was significantly increased in pre-eclampsia and HELLP compared with controls and placental insufficiency patients (mean concentrations: 343, 324, 248, 227 nmol/l; p=0.001). Homocysteine, folic acid, vitamin B6 and methylmalonic acid, however, did not differ significantly between groups. The main determinants of cystathionine are cystatin C and vitamin B6, whereas the main determinants of homocysteine are folate and uric acid. The strongest dependency of cystathionine on vitamin B6 was observed in pre-eclampsia and HELLP patients. The results suggest that the vitamin B6-dependent trans-sulfuration pathway is activated in pre-eclampsia and HELLP syndrome, probably by oxidative stress. Therefore, the demand for vitamin B6 is increased in these patients. Furthermore, renal dysfunction and low vitamin B6 levels contribute to the increase of cystathionine in pre-eclampsia and HELLP patients.

Keywords: cystathionine; hemolysis, elevated liver enzymes, low platelet (HELLP) syndrome; homocysteine; oxidative stress; pre-eclampsia

References

  • 1

    Hubel CA. Oxidative stress in the pathogenesis of pre-eclampsia. Proc Soc Exp Biol Med 1999; 222:222–35.CrossrefGoogle Scholar

  • 2

    Krauss T, Emons G, Kuhn W, Augustin HG. Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin Chem 2002; 48:1418–25.Google Scholar

  • 3

    Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ. Does endothelial cell activation occur with intrauterine growth restriction? Br J Obstet Gynaecol 2002; 109:836–9.Google Scholar

  • 4

    Herrmann W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med 2001; 39:666–74.Google Scholar

  • 5

    Stanger O, Weger M, Renner W, Konetschny R. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease. Clin Chem Lab Med 2001; 39:725–33.Google Scholar

  • 6

    Yamamoto M, Hara H, Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial surface. FEBS Lett 2000; 486:159–62.Google Scholar

  • 7

    Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, et al. Plasma homocysteine concentration is increased in pre-eclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998; 179:1605–11.Google Scholar

  • 8

    Leeda M, Riyazi N, de Vries JIP, Jakobs C, van Geijn HP, Dekker GA. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of pre-eclampsia or fetal growth restriction. Am J Obstet Gynecol 1998; 179:135–9.Google Scholar

  • 9

    Rajkovic A, Mahomed K, Malinow MR, Sorensen TK, Woelk GB, Williams MA. Plasma homocyst(e)ine concentrations in eclamptic and pre-eclamptic African women postpartum. Obstet Gynecol 1999; 94:355–60.Google Scholar

  • 10

    Wang J, Trudinger BJ, Duarte N, Wilcken DE, Wang XL. Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia. Br J Obstet Gynaecol 2000; 107:935–8.Google Scholar

  • 11

    Cotter A, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe pre-eclampsia. Am J Obstet Gynecol 2001; 185:781–5.Google Scholar

  • 12

    Murphy MM, Scott JM, McPartlin JM, Fernandez-Ballart JD. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 2002; 76:614–9.Google Scholar

  • 13

    Geisel J, Hübner U, Bodis M, Schorr H, Knapp JP, Obeid R, et al. The role of genetic factors in the development of hyperhomocysteinemia. Clin Chem Lab Med 2003; 41:1427–34.Google Scholar

  • 14

    Cikot RJLM, Steegers-Theunissen RPM, Thomas CMG, De Boo TM, Merkus HMW, Steegers EAP. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 2001; 85:49–58.Google Scholar

  • 15

    Herrmann W, Schorr H, Obeid R, Geisel J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomo-cysteinemia in vegetarians. Am J Clin Nutr 2003; 78:131–6.Google Scholar

  • 16

    Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997; 52:495–502.Google Scholar

  • 17

    Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin and folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988; 81:466–74.Google Scholar

  • 18

    Mosharov E, Cranford MR, Banerjee J. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000; 39:13005–11.Google Scholar

  • 19

    Taoka S, Lepore BW, Kabil Ö, Ojha S, Ringe D, Banerjee R. Human cystathionine β-synthase is a heme sensor protein. Evidence that the redox sensor is heme and not the vicinal cysteines in the CXXC motif seen in the crystal structure of the truncated enzyme. Biochemistry 2002; 42:10454–61.CrossrefGoogle Scholar

  • 20

    Anim-Nyame N, Gamble J, Sooranna SR, Johnson MR, Steer PJ. Microvascular permeability is related to circulating levels of tumor necrosis factor-α in pre-eclampsia. Cardiovasc Res 2003; 58:162–9.Google Scholar

  • 21

    Zou CG, Banerjee R. Tumor necrosis factor-α induced targeted proteolysis of cystathionine β-synthase modulates redox homeostasis. J Biol Chem 2003; 278:16802–8.Google Scholar

  • 22

    Malmezat T, Breuillé D, Pouyet C, Buffière C, Denis P, Mirand PP, et al. Methionine transsulfuration is increased during sepsis in rats. Am J Physiol Endocrinol Metab 2000; 279:E1391–7.Google Scholar

  • 23

    Sturman JA, Cohen PA, Gaull G. Effects of deficiency of vitamin B6 on transsulfuration. Biochem Med 1969; 3:244–5.CrossrefGoogle Scholar

  • 24

    Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler SP, Riezler R, et al. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest 1996; 98:177–84.Google Scholar

  • 25

    Herrmann W, Schorr H, Geisel J, Riegel W. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med 2001; 39:739–46.Google Scholar

  • 26

    Sorensen TK, Malinov MR, Williams MA, King IB, Luthy DA. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of pre-eclampsia. Gynecol Obstet Invest 1999; 48:98–103.Google Scholar

  • 27

    Hogg B, Tamura T, Johnston KE, Dubard MB, Goldenberg RL. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, pre-eclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2000; 183:805–9.Google Scholar

  • 28

    Infante-Rivard C, Rivard GE, Gauthier R, Theoret Y. Unexpected relationship between plasma homocysteine and intrauterine growth restriction. Clin Chem 2003; 49:1476–82.CrossrefGoogle Scholar

  • 29

    van Guldner C, Kulik W, Berger R, Dijkstra DA, Jakobs C, Reijngoud DJ, et al. Homocysteine and methionine metabolism in ESRD: a stable isotope study. Kidney Int 1999; 56:1064–71.Google Scholar

  • 30

    McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B12 deficiency and Alzheimer disease. Neurology 2002; 58:1395–9.Google Scholar

  • 31

    Conrad KP, Lindheimer MD. Renal and cardiovascular alterations. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley’s hypertensive disorders in pregnancy. Stamford, CT: Appleton & Lange, 1999:263–326.Google Scholar

  • 32

    Powers RW, Majors AK, Kerchner LJ, Conrad KP. Renal handling of homocysteine during normal pregnancy and pre-eclampsia. J Soc Gynecol Invest 2004; 11:45–50.CrossrefGoogle Scholar

  • 33

    Stead LM, Au KP, Jacobs RL, Brosnan M, Brosnan JT. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am J Physiol Endocrinol Metabol 2001; 281:E1095–100.Google Scholar

  • 34

    Wachstein M, Graffeo LW. Influence of vitamin B6 on the incidence of pre-eclampsia. Obstet Gynecol 1956; 8:177–80.Google Scholar

  • 35

    Chang SJ. Adequacy of maternal pyridoxine supplementation during pregnancy in relation to the vitamin B6 status and growth of neonates at birth. J Nutr Sci Vitaminol 1999; 45:499–558.Google Scholar

  • 36

    Schuster K, Bailey LB, Mahan CS. Effect of maternal pyridoxine HCl supplementation on the vitamin B6 status of mother and infant and on pregnancy outcome. J Nutr 1984; 114:977–88.Google Scholar

  • 37

    Holdsworth CD, Atkinson M, Dossett JA, Hall R. An assessment of the diagnostic and prognostic value of serum vitamin B12 levels in liver disease. Gut 1964; 5:601–6.CrossrefGoogle Scholar

  • 38

    Hernández-Díaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension to folic acid supplementation during pregnancy. Am J Epidemiol 2002; 156:806–12.Google Scholar

  • 39

    Sanchez SE, Zhang C, Malinow MR, Ware-Jauregui S, Larrabure G, Williams MA. Plasma folate, vitamin B12, and homocyst(e)ine concentrations in pre-eclamptic and normotensive Peruvian women. Am J Epidemiol 2001; 153:474–80.Google Scholar

  • 40

    Ray JG, Mamdani MM. Association between folic acid food fortification and hypertension or pre-eclampsia in pregnancy. Arch Intern Med 2002; 162:1776–7.Google Scholar

  • 41

    Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999; 354:810–6.Google Scholar

About the article

Received: 2004-04-08

Accepted: 2004-08-20

Published Online: 2005-06-01

Published in Print: 2004-10-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2004.228.

Export Citation

© Walter de Gruyter. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
B. Demir, S. Demir, S. Pasa, S. Guven, Y. Atamer, A. Atamer, and Y. Kocyigit
Journal of Obstetrics & Gynaecology, 2012, Volume 32, Number 6, Page 525
[2]
Hiten D. Mistry, Joanna Mather, Margaret M. Ramsay, Lesia O. Kurlak, Michael E. Symonds, and Fiona Broughton Pipkin
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2011, Volume 1, Number 2, Page 150
[3]
Laura Mazzanti, Monia Cecati, Arianna Vignini, Sara D'Eusanio, Monica Emanuelli, Stefano R. Giannubilo, Franca Saccucci, and Andrea L. Tranquilli
American Journal of Obstetrics and Gynecology, 2011, Volume 205, Number 3, Page 236.e1
[4]
Wolfgang Herrmann, Sonia Isber, Rima Obeid, Markus Herrmann, and Muhidien Jouma
Clinical Chemical Laboratory Medicine, 2005, Volume 43, Number 10
[5]
Yurdanur G. Acılmıs, Ebru Dikensoy, Ali I. Kutlar, Ozcan Balat, Fatma B. Cebesoy, Ebru Ozturk, Hulya Cicek, and Sadrettin Pence
Journal of Obstetrics and Gynaecology Research, 2011, Volume 37, Number 1, Page 45
[6]
Dongwei Mao, Jianhua Che, Keshen Li, Shiyu Han, Qi Yue, Li Zhu, Wei Zhang, and Lin Li
Archives of Gynecology and Obstetrics, 2010, Volume 282, Number 4, Page 371
[7]
Monica Emanuelli, Davide Sartini, Valentina Rossi, Alessandra Corradetti, Beatrice Landi, Claudia Regina Vianna, Stefano Giannubilo, and Andrea Luigi Tranquilli
Cell Stress and Chaperones, 2008, Volume 13, Number 1, Page 67

Comments (0)

Please log in or register to comment.
Log in